Vnitr Lek. 2007 May;53(5):512-20.
Diabetic retinopathy is the most serious diabetic complication. Modern pharmacotherapy offers a wide range of potential treatments (ACE inhibitors, sartans, hypolipidemic drugs, drugs influencing proteinkinase C and vascular endotelial growth factor etc.). Diabetic retinopathy was previously treated surgically but...
Journal francais d'ophtalmologie
J Fr Ophtalmol. 2011 Sep;34(7):491-7. doi: 10.1016/j.jfo.2011.04.007. Epub 2011 Jun 21.
Even if several studies have clearly demonstrated that a good control of glycemia and arterial pressure allow reducing the incidence and the progression of diabetic retinopathy, there is currently no drug treatment to prevent the incidence or progression of...
Future medicinal chemistry
Sahajpal NS, Chaubey A, Goel RK, Jain SK.
Future Med Chem. 2018 Oct 01;10(19):2249-2252. doi: 10.4155/fmc-2018-0233. Epub 2018 Sep 14.
No abstract available.
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Geng S, Ye JJ.
Zhonghua Yan Ke Za Zhi. 2008 Jan;44(1):76-81.
Diabetic retinopathy is a common complication of diabetes mellitus. Studies on the pathogenesis of diabetic retinopathy are important for the prevention and treatment of this disease. Neurodegeneration and microvascular dysfunction are the major events of diabetic retinopathy happened in...
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Am J Health Syst Pharm. 2007 Sep 01;64(17):S15-21. doi: 10.2146/ajhp070332.
PURPOSE: The goal of treatment of diabetic retinopathy, limitations of laser photocoagulation, endpoints used in clinical studies of diabetic retinopathy treatments, and the mechanism of action, efficacy, and safety of several new and emerging therapies targeting the biochemical pathways...